Lawmakers urge FDA to consider broad exemptions from DSCSA to minimize supply chain disruptions
Regulatory NewsJoanne S. Eglovitch
ComplianceDSCSAEnforcementPharmaceuticalsShortagesSupply Chain ManagementUnited StatesRegulatory NewsJoanne S. EglovitchComplianceDSCSAEnforcementPharmaceuticalsShortagesSupply Chain ManagementUnited States